These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3541810)

  • 1. The interaction of the naphthoquinone derivative menoctone and dihydrofolate reductase inhibitors on Plasmodium falciparum in vitro.
    Percy M; Howells RE
    Ann Trop Med Parasitol; 1986 Jun; 80(3):359-60. PubMed ID: 3541810
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
    Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
    Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
    Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
    Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
    Bhasin VK; Nair L
    Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs.
    McRobert L; Jiang S; Stead A; McConkey GA
    Exp Parasitol; 2005 Nov; 111(3):178-81. PubMed ID: 16140296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of molecular genetics to the understanding of chemoresistance of Plasmodium falciparum].
    Le Bras J; Basco LK; Cremer G; Charmot G
    Bull Soc Pathol Exot; 1992; 85(2):146-9. PubMed ID: 1356539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
    Ang HH; Cheang HS; Mak JW
    Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.
    Jones K; Ward SA
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2700-3. PubMed ID: 12121961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum.
    Yeo AE; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1992; 86(3):234. PubMed ID: 1412640
    [No Abstract]   [Full Text] [Related]  

  • 14. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
    Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
    Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.
    Ang HH; Lam CK; Wah MJ
    Chemotherapy; 1996; 42(5):318-23. PubMed ID: 8874969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya.
    Spencer HC; Watkins WW; Sixsmith DG; Koech DK
    Trans R Soc Trop Med Hyg; 1986; 80(2):201-3. PubMed ID: 3538522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
    Hekmat-Nejad M; Rathod PK
    Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.